Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey
DOI:
https://doi.org/10.3855/jidc.17910Keywords:
Hepatitis C, anti-HCV, screening, treatment, TurkeyAbstract
Introduction: The aim of this national, multicenter, cross-sectional, retrospective chart review study was to determine the proportion of patients in Turkey who received hepatitis C virus (HCV) treatment after receiving positive anti-HCV results during HCV screening.
Methodology: Data related to patients’ demographics, laboratory results, time interval from obtaining a positive anti-HCV result to treatment initiation, specialty of the physician requesting anti-HCV screening, and type of hospital were analyzed.
Results: Among 1,000 patients who received a positive anti-HCV result, 50.3% were male and 78.5% were screened for HCV-RNA. Among HCV-RNA screened patients, 54.8% (n = 430) had a positive result. Among patients who tested positive for HCV-RNA, 72.8% received HCV treatment in line with their positive anti-HCV results. The median time from obtaining a positive anti-HCV result to initiation of HCV treatment was 91.0 days (interquartile range 42.0 to 178.5). Non-surgical branches requested HCV-RNA testing more frequently than surgical branches (p < 0.001). The rate of access to HCV treatment was higher among patients screened in university hospitals than among patients screened in training and research hospitals (p < 0.001).
Conclusions: Our results indicate a higher rate of treatment initiation among patients with HCV infection than is described in the published literature. Furthermore, the time from screening to treatment initiation was considerably shorter compared with other international studies. However, since HCV-RNA testing was not requested in a significant portion of patients with a positive anti-HCV test result, there might be a large patient population with HCV who do not receive treatment.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Mustafa Kemal Çelen, Buket Ertürk Şengel, Şafak Kaya, Neşe Demirtürk, Alpay Azap, Hüsnü Pullukçu, Esma Eroğlu, Figen Yıldırım, Hüseyin Şener Barut, Esra Zerdali, Ayşe Sağmak Tartar, Ayşe Özlem Mete, Ahmet Melih Şahin, Bedia Mutay Suntur, Nagehan Didem Sarı, Emel Yılmaz, Aslıhan Candevir, Funda Şimşek, Dilara İnan, Sıla Akhan, Ali Asan, Özgür Günal, Onur Ural, Mehmet Parlak, Mehmet Çabalak, Selçuk Nazik, Kenan Hızel, Sami Kınıklı, Zehra Beştepe Dursun, Ayşe Batırel, Çiğdem Mermutluoğlu
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
